BAY 1135626
Product Sizes
50 mg
£ POA
HY-147281-50MG
100 mg
£ POA
HY-147281-100MG
1 mg
£ POA
HY-147281-1MG
5 mg
£ POA
HY-147281-5MG
25 mg
£ POA
HY-147281-25MG
10 mg
£ POA
HY-147281-10MG
About this Product
- SKU:
- HY-147281
- Application:
- Antibody Microarray
- CAS Number:
- 1404071-37-9
- Extra Details:
- BAY 1135626 is used to synthesize BAY 1129980; and use to anti-tumor research. BAY 1129980 is a Auristatin-based anti-C4.4A (LYPD3) antibody–agent conjugate (ADC); is used to non–small cell lung cancer (NSCLC) research[1].
- Molecular Weight:
- 1063.33
- Purity:
- 99.19
- References:
- [1]Willuda J, et al. Preclinical Antitumor Efficacy of BAY 1129980-a Novel Auristatin-Based Anti-C4.4A (LYPD3) Antibody-Drug Conjugate for the Treatment of Non-Small Cell Lung Cancer. Mol Cancer Ther. 2017 May. 16(5):893-904.
- Research Area:
- Cancer
- Shipping Conditions:
- Ambient
- Storage Conditions:
- 4[o]C (Powder; protect from light)
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules: Conjugated Protein
- Pathway:
- Antibody-drug Conjugate/ADC Related
